COMPANY PROFILE · UPDATED 18 NOV 2025

Gilgamesh Pharmaceuticals

Gilgamesh is a pioneering early-stage biotech developing novel compounds that build upon the benefits of classic psychedelics with improvements of other components such as safety, tolerability, duration, and efficacy. Mental health…

gilgameshpharmaceutical.com ↗

This profile is unclaimed — do you work here? Claim it

Claim it →

Founded: 2019
Headcount: 24
Open roles: 0
Last raised: Grant · Sign in to view

LEADERSHIP

Founders & key people

Dalibor Sames

Founder at Gilgamesh Pharmaceuticals

Gilgamesh PharmaceuticalsColumbia University

Andrew Kruegel

President at Kures

KuresColumbia UniversityRocheGilgamesh PharmaceuticalsColumbia UniversityStevens Institute of Technology

Jonathan Sporn

CEO at Gilgamesh Pharmaceuticals

Gilgamesh PharmaceuticalsPerception NeurosciencePfizer Inc.Johnson & JohnsonJohnson & Johnson Pharmaceutical Research & DevelopmentJohnson & Johnson Pharamceutical Research and Development (JJPRD)University of Miami, Miller School of MedicineDuke University

Jeff Witkin

CEO at Witkin Consulting Group

Witkin Consulting GroupLaboratory of Antiepileptic Drug Discovery, Peyton Manning Hospital for ChildrenRespireRx Pharmaceuticals InDepartment of Chemistry & Biochemistry, University Wisconsin-MilwaukeeEli Lilly and CompanyNIDA Intramural Research ProgramUniversity of North Carolina at Chapel Hill - UNCUniversity of Maryland

Mike Cunningham

Founder at Gilgamesh Pharmaceuticals

Gilgamesh PharmaceuticalsColumbia UniversityUniversity of MississippiUniversity of Mississippi, Office of Research and Sponsored ProgramsUniversity of Mississippi, Graduate Student CouncilESL Conversation Partners Program, Texas State UniversityMississippi State UniversityUniversity of Mississippi

OPEN ROLES

Hiring at Gilgamesh Pharmaceuticals

No open roles listed right now. Check back soon or search all jobs →

FUNDING

Capital raised

Total Amount Raised: $82,559,840